Cancer · 2020
Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical process.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Perni Subha, Milligan Michael G, Saraf Anurag, Vivenzio Todd, Marques Amy, Baker Meghan A, Kosak Tara, Bartlett Sarah, Physic Michelle A, Batchelder Monica R, McBride Sean, Bredfeldt Jeremy, Cail Daniel W, Kearney Meghan C, Whitehouse Colleen, Orio Peter, Walsh Gerard, Haas-Kogan Daphne A, Martin Neil E
Аннотация
The treatment of patients with cancer who test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses unique challenges. In this commentary, the authors describe the ethical rationale and implementation details for the creation of a novel, multidisciplinary treatment prioritization committee, including physicians, frontline staff, an ethicist, and an infectious disease expert. Organizational obligations to health care workers also are discussed. The treatment prioritization committee sets a threshold of acceptable harm to patients from decreased cancer control that is justified to reduce risk to staff. The creation of an ethical, consistent, and transparent decision-making process involving such frontline stakeholders is essential as departments across the country are faced with decisions regarding the treatment of SARS-CoV-2-positive patients with cancer.